Ferrous sulphate

PreclinicalSmall molecule

VVifor Pharma

Ferrous sulphate is one of 7 small molecule programs targeting Iron-deficiency. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Iron-DeficiencyTerminated

SchistosomiasisActive, not recruiting

Iron-DeficiencyPreclinical

Terminated

SchistosomiasisPreclinical

Active, not recruiting

Competition

Competitive Landscape

6 competitors in Schistosomiasis

#DrugCompanyPhaseTrials

Biltricide

Bayer

Approved

7 2

Daraprim

FFondazione Matilde Tettamanti Menotti De Marchi Onlus

Artesunate

Ferrous sulphate

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Anemia3 trials

Study on Preventing Anemia in Children in Ghana

Completed·GGhana Health Services·N/A·NCT00301054·872 enrolled

Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia

Completed·UUniversity Medical Centre Ljubljana·Phase 3·NCT03957057·300 enrolled

Use of Iron Isomaltoside 1000 (Monofer) in Postpartum Anemia

Completed·—·N/A·NCT01628770·271 enrolled

Efficacy and Safety2 trials

Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women

Completed·VVifor Pharma·Phase 3·NCT01131624·252 enrolled

The Efficacy and Safety of Iron Supplementation

Unknown status·IImperial College London·N/A·NCT01590134·18 enrolled

Terminated·IImperial College London·N/A·NCT01908543·3 enrolled

6 more indications

Lip1 trial

Ulipristal Use in Chinese Population

Terminated·QQueen Mary Hospital, Hong Kong·Phase 4·NCT02825719·31 enrolled

Treatment1 trial

Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors

Completed·UUniversity of Lausanne·Phase 4·NCT00689793·154 enrolled

Iron deficiency anemia1 trial

Effectiveness of Oral Iron Therapy in Iron Deficiency Anemia With Daily vs Alternate Day Dosing

Completed·UUniversity of Child Health Sciences and Children's Hospital, Lahore·Phase 3·NCT07267975·60 enrolled

Inflammatory Bowel Disease1 trial

Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate

Completed·QQueen Mary University of London·Phase 4·NCT01991314·90 enrolled

Colorectal Cancer1 trial

IVICA: Intravenous Iron in Colorectal Cancer Associated Anaemia

Completed·NNottingham University Hospitals NHS Trust·Phase 4·NCT01701310·116 enrolled

Efficacy1 trial

An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function

Completed·—·N/A·NCT05309499·298 enrolled

Sources

References

[1]
ClinicalTrials.gov — 14 trial records for Ferrous sulphate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Ferrous sulphate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Ferrous sulphate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Vifor Pharma company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: VVifor Pharma

Ferrous sulphate

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Anemia3 trials

Efficacy and Safety2 trials

Schistosomiasis1 trial

Hip Fracture1 trial

Iron-deficiency1 trial

Lip1 trial

Treatment1 trial

Iron deficiency anemia1 trial

Inflammatory Bowel Disease1 trial

Colorectal Cancer1 trial

Efficacy1 trial

References

Drug Info

Quick Facts

Related News